News

‘eVIN system being repurposed for tracking vaccine delivery’

Harsh-Vardhan

eVIN system, the digital platform used in the Universal Immunisation Programme is being repurposed to digitally track movement of stocks of Covid-19 vaccines, once available, Union Health Minister Harsh Vardhan said recently.

While interacting with the Confederation of Indian Industries (CII) via a video link, he said the platform would also trace those who will receive the shots thus ensuring last-mile vaccine delivery.

He mentioned that under Mission Indradhanush, the government has already ramped up its immunisation capability with an elaborate cold storage chain for inoculating children from 12 diseases.

Also read: ‘Covid-19 vaccine programme to cover over 25 cr people by July 2021’

“The entire eVIN platform is being repurposed as COVIN Network. All movement of stock can be digitally tracked and those receiving vaccines can also be traced after two to three weeks if the vaccine requires two shots. This will ensure last-mile vaccine delivery,” Vardhan was quoted as saying in a statement by a PTI report.

He also highlighted India’s tryst with the coronavirus pandemic as an evidence of cooperation between the public and private sectors.

“Our nation has now become one of the largest manufacturers of personal protective equipment kits. We used to send samples to CDC Atlanta for testing a few years back while we now have private testing labs contributing to the total testing capacity of the country,” the minister was quoted saying by the report.

Highlighting the role of technology in scaling up things during COVID-19, Vardhan said, “We need to maximise the potential that technology has provided us and leverage this in our fight towards healthcare for all.”

“Telemedicine has come to the fore and has provided us with a solution for last-mile connectivity. Today, the eSanjeevani teleconsultation service has completed 8 lakh consultations.”

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Follow us on


Most Popular

Subscribe Newsletter
To Top